Preview Mode Links will not work in preview mode
  1. All Episodes
  2. Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Oct 4, 2024

Featuring perspectives from Dr Joshua Brody, Dr Matthew Lunning and Dr Jason Westin, moderated by Dr Lunning, including the following topics:

  • Introduction (0:00)
  • Integration of Chimeric Antigen Receptor (CAR) T-Cell Therapy into the Management of Diffuse Large B-Cell Lymphoma — Dr Westin (1:34)
  • Current Role of CAR T-Cell Therapy for Other B-Cell Lymphomas — Dr Lunning (21:17)
  • Tolerability and Other Practical Considerations with CAR T-Cell Therapy — Dr Brody (40:15)

CME information and select publications